Morningstar just downgraded its long-term (five-year) EPS growth forecast from 9.67% to 9.19% CAGR. The S&P 500 has ...

U.S. stocks end the week on a high, as S&P 500 reclaims the 6,000-point mark for the first time since February. Read more ...

Fresenius offers international diversification, stable healthcare exposure, and upside from a strategic pivot. Find out why ...

TFI International remains a strong buy with solid cash flow, strategic growth, and new buying opportunities amid a recovering ...

Uncertainty is the word of the year, for an environment dominating by a unique array of uncertainties - policy, market, ...

Demand for private credit continues to surge, with projections suggesting it could hit $2.8 trillion by 2028. Read more here.

USCL ETF has climate-conscious exposure to top companies like Nvidia and Microsoft with a low expense ratio. Read an in-depth ...

Northwest Pipe's growth is set to surge in FY25, with improving margins, strong order momentum, and favorable stock valuation ...

Torrid Holdings faces revenue challenges, e-commerce risks, and industry pressures. See here to know why we recommend a sell ...

The median risk of default for publicly traded US companies rose across most sectors from the end of March through the end of ...

CAVA's expansion boosts revenue, but slowing sales and high valuation raise concerns. Read here for an analysis of CAVA stock ...

Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...